Breast cancer continues to pose a significant global health challenge as the most commonly diagnosed cancer in women ...

Dr. Marla Lipsyc-Sharf reviews her recent session at the 2024 SABCS meeting, discussing biopsy approaches and treatment ...

Raez, MD, discusses the current liquid biopsy options for patients with lung cancer through ... or detecting ctDNA in the blood with tumor genotype-uninformed tests. Raez highlights the debate between ...

BioMark Expands Its Liquid Biopsy Platform Receptor Status for Breast Cancer Vancouver, British Columbia--( - December 10, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ...

The technology of liquid biopsy, which analyzes components in bodily fluids such as blood or urine to diagnose diseases, is gaining attention in the medical field. According to global market ...

In a statement, the UK medical device firm said its "liquid biopsy" approach "offers the prospect of a new era of personalised cancer care" and moves it closer to positioning Parsortix as a go-to ...

The lawsuit, first filed in May 2021, centers on Guardant’s Reveal liquid biopsy test ... Reveal, meanwhile, is designed to rely only on blood plasma. In addition, Guardant had claimed that ...

Discover how voided urine cfDNA emerges as a promising biomarker for upper tract urothelial carcinoma, offering a less ...

A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer, a study suggests.

Revolutionary AI blood test detects breast cancer in its earliest stages, offering a non-invasive, life-saving diagnostic ...

"Aspyre Clinical Test for Lung's unmatched next day turnaround time coupled with its best-in-class performance from tissue and blood and proven performance with challenging samples makes ...

BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a leader in liquid biopsy tests for early cancer detection ...